The Merck GHI-backed medical device developer had raised $120m in funding prior to its initial public offering.
US-based medical device developer ElectroCore has raised $78m in an initial public offering that secured an exit for pharmaceutical firm Merck & Co’s Global Health Innovation (GHI) Fund.
The offering consisted of 5.2 million shares issued on the Nasdaq Global Market priced at $15 each. The company’s shares opened at $18.94 on their first day of trading on Friday and are trading at $19.00 at time of publication.
ElectroCore has developed a device called GammaCore that treats pain caused…
